SALLY W PULLMAN MOOAR

Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology WILLOW GROVE, PA NPI 1912930702

General Payments — all program years on this page

$1,819.83

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 98
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $550.20 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $450.2120
Education $99.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $24.752
2020 $324.0222
2021 $148.0810
2022 $113.427
2023 $659.3636
2024 $550.2021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078606936 Janssen Biotech, Inc. $22.56 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078607011 Janssen Biotech, Inc. $33.26 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078607063 Janssen Biotech, Inc. $31.56 05/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078607111 Janssen Biotech, Inc. $99.99 05/14/2024 Education Undisputed 01/23/2026 View at CMS
1087264975 Novartis Pharmaceuticals Corporation $17.98 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089364873 Sandoz Inc. $20.91 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089364875 Sandoz Inc. $19.33 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093893416 Alexion Pharmaceuticals, Inc. $27.70 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101586810 E.R. Squibb & Sons, L.L.C. $31.37 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101586819 E.R. Squibb & Sons, L.L.C. $19.16 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101586841 E.R. Squibb & Sons, L.L.C. $22.52 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105324969 ABBVIE INC. $22.59 02/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105324973 ABBVIE INC. $19.83 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105324977 ABBVIE INC. $25.74 04/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116031745 Amgen Inc. $18.89 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116031752 Amgen Inc. $19.52 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117659854 Amgen Inc. $17.62 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118233736 Boehringer Ingelheim Pharmaceuticals, Inc. $13.98 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135370504 Lilly USA, LLC $23.38 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136199112 Organon Llc $24.47 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143086938 UCB, Inc. $17.84 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.